On the one hand, the company is struggling to stay competitive with its chief rival Eli Lilly, and on the other, compounders ...

The entertainment giant is counting on the two businesses to help it deal with cord-cutting and an up-and-down movie division. The chain's effort to rebuild its reputation for fast, affordable food is ...

Novo Nordisk, the Danish pharma heavyweight behind Ozempic, is feeling the squeeze as its once-booming diabetes drug sales ...

Novo Nordisk A/S (NYSE:NVO) on Wednesday reported second-quarter 2025 sales of roughly $11.68 billion (76.86 billion Danish ...

Second quarter earnings season is in full swing, and the results have been largely positive so far, with more positive ...

The entertainment giant is counting on the two businesses to help it deal with cord-cutting and an up-and-down movie division. Uber Technologies logged higher-than-expected financial results in the ...

Novo Nordisk faces a sharp decline in sales of its injectable diabetes drugs, including Ozempic, due to intense competition ...

On rare occasions, our expert team of analysts issues a “Double Down” stock recommendation for companies that they think are ...

Second quarter earnings season is in full swing, and the results have been largely positive so far, with more positive ...

US president Donald Trump said in an interview with CNBC last night that tariffs on semiconductors and pharma would be ...

Advanced Micro Devices ( AMD -1.39%) upped its Q3 revenue guidance to $8.4 billion to $9 billion, and Q2's $7.7 billion ...

Advanced Micro Devices (NASDAQ: AMD) stock sank 6.2% after the chipmaker unveiled underwhelming quarterly revenue at its ...